![Omeros Corporation logo](/logos/OMER.webp)
Omeros Corporation
NASDAQ:OMER
Overview | Financials
Company Name | Omeros Corporation |
Symbol | OMER |
Currency | USD |
Price | 3.64 |
Market Cap | 210,926,716 |
Dividend Yield | 0% |
52-week-range | 0.92 - 5.68 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Gregory A. Demopulos M.D. |
Website | https://www.omeros.com |
An error occurred while fetching data.
About Omeros Corporation
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD